Effect of Weight Reduction on Inflammatory Markers and Genes Expression in Obese Individuals

This study has been completed.
Information provided by:
Taichung Veterans General Hospital
ClinicalTrials.gov Identifier:
First received: December 25, 2006
Last updated: December 26, 2006
Last verified: December 2006
To investigate whether weight reduction by life style modification for 12 weeks will improve circulating inflammatory markers, adipocytokines as well as gene expression of proinflammatory protein obtained from circulating monocytes from obese individuals.

Condition Intervention
Behavioral: Lifestyle modification

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label

Resource links provided by NLM:

Further study details as provided by Taichung Veterans General Hospital:

Primary Outcome Measures:
  • Inflammatory responses after weight reduction

Secondary Outcome Measures:
  • BMI
  • Circulating inflammatory markers
  • Adipocytokines
  • Gene Expression from mononuclear cells

Estimated Enrollment: 25
Study Start Date: May 2005
Estimated Study Completion Date: November 2005

Ages Eligible for Study:   20 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Nondiabetes obese individuals with BMI greater than 27 kgs/m2

Exclusion Criteria:

  • Diabetes
  • Abnormal hepatic, renal and cardiac function
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00416156

Taichung Veterans General Hospital
Taichung, Taiwan
Sponsors and Collaborators
Taichung Veterans General Hospital
Principal Investigator: Wayne H Sheu, MD, PhD Taichung Veterans General Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00416156     History of Changes
Other Study ID Numbers: TCVGH 05082 
Study First Received: December 25, 2006
Last Updated: December 26, 2006
Health Authority: Taiwan: Department of Health

Keywords provided by Taichung Veterans General Hospital:

Additional relevant MeSH terms:
Pathologic Processes

ClinicalTrials.gov processed this record on May 26, 2016